SCHEMBL7973100

SCHEMBL7973100

NCCCCN1CCc2cc(OC(F)(F)F)ccc2C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.48
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
HRH3 Q9Y5N1 2/20 0.46
MOGAT2 Q3SYC2 2/20 0.44
HTR5A P47898 1/20 0.43
HTR7 P34969 2/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
HTR2A P28223 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979867 0.95 PRMT5 (0.46) ACACBPRMT5WDR77HRH3HTR5A
SCHEMBL7962844 0.81 ACACB (0.45) ACACBHTR7HTR1ADRD2HTR2A
SCHEMBL7976536 0.80 DRD3 (0.52) ACACBPRMT5WDR77DRD2DRD3
SCHEMBL6977341 0.80 DRD2 (0.61) DRD2DRD3
SCHEMBL22099626 0.79 SLC6A2 (0.55) DRD2DRD3SLC6A2SLC6A4SLC6A3
SCHEMBL6975839 0.78 ABCB1 (0.55) HRH3
SCHEMBL7639198 0.78 ACACB (0.44) ACACBPRMT5WDR77HRH3MOGAT2
SCHEMBL7853889 0.76 DRD3 (0.65) PRMT5WDR77HTR7HTR1ADRD2
SCHEMBL7979148 0.76 CARM1 (0.49) ACACBPRMT5HTR7DRD2DRD3
SCHEMBL18034983 0.76 DRD1 (0.60) ACACBHRH3DRD2HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274593-B1 TREATING PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA, AND PARKINSON*S DISEASE SMITHKLINE BEECHAM P.L.C. (GB) 2001-08-14 US disclosed
EP-0980357-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-02-23 EP disclosed
WO-1998050363-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed